Abstract

Results Good correlations were found between VE-MRI and TDI at the septum (patients r = 0.88, p < 0.001, controls r = 0.96, p < 0.001), RVFW (patients r = 0.90, p < 0.001, controls r = 0.93, p < 0.001) and RVOT (patients r = 0.92 p < 0.001, controls 0.76, p < 0.001). No significant differences between the techniques were observed at the RVFW (Table 1). VE-MRI measured slightly later timings than TDI in patients at the septum (difference 0.7%, p = 0.002) At the RVOT, VE-MRI measured slightly later timings in controls (difference 0.9%, p = 0.005). Although statistically significant, the observed differences are very small and therefore probably not clinically relevant. Conclusion VE-MRI is an accurate tool to assess timings of RV mechanics in healthy controls and in cToF patients. In the future, VE-MRI may aid in the selection of cToF patients for CRT. Comparison of timings to peak systolic velocities of the right ventricle between TDI and VE-MRI. Timings are expressed as percentage of the cardiac cycle. Abbreviations: cToF: corrected Tetralogy of Fallot, IVS: interventricular septum, RVFW: right ventricular free wall, RVOT: right ventricular outflow tract.

Highlights

  • In corrected Tetralogy of Fallot (cToF) patients, Cardiac resynchronisation therapy (CRT) has proven to be a successful treatment for right ventricular (RV) failure

  • Knowledge of timings of RV mechanics in healthy controls and cToF patients is important to identify which patients could benefit from CRT

  • Good correlations were found between Velocity-Encoded Magnetic Resonance Imaging (VE-MRI) and Tissue Doppler Imaging (TDI) at the septum, RV free wall (RVFW) and right ventricular outflow tract (RVOT)

Read more

Summary

Introduction

In cToF patients, Cardiac resynchronisation therapy (CRT) has proven to be a successful treatment for RV failure. Published: 21 January 2010 Journal of Cardiovascular Magnetic Resonance 2010, 12(Suppl 1):P7 doi:10.1186/1532-429X-12-S1-P7 Abstracts of the 13th Annual SCMR Scientific Sessions - 2010 Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here. http://www.biomedcentral.com/content/files/pdf/1532-429X-11-S1-info

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.